Plastic Chemical BPA is “Of Some Concern” to Children, FDA Says (Finally)
After months of waiting for the Food and Drug Administration to announce its new stance on the safety of the controversial plastic chemical bisphenol A (BPA), we now know the answer. 
FDA Hasn’t Learned Its Lesson From Vioxx Fiasco
Three years since major changes were recommended for how the Food and Drug Administration monitors drug safety after the Vioxx painkiller scandal, the federal agency has yet to implement most of the suggested improvements, according to Congressional investigators.
Should Big Pharma Really Be Your Facebook Friend?
Imagine among the slew of online updates you get about the daily comings and goings of your Facebook friends and tweets about the latest YouTube video of a cat playing drums, in comes a post about a new brand-name drug.
LexisNexis® Legal News Podcast for February 8, 2010
The Securities and Exchange Commission and Bank of America agree to a $150 million settlement of executive compensation lawsuits, and, the D.C. Circuit reinstates a ban on e-cigarette imports pending appeal. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
LexisNexis® Legal News Podcast for February 3, 2010
A Pennsylvania judge slashes a $75 million punitive damages award in a Prempro case, and, the 1st Circuit finds an artist has a viable copyright claim against a Massachusetts museum. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2010 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
LexisNexis® Legal News Podcast for February 2, 2010
The Madoff trustee reaches a $220 million settlement with investors of Bernard Madoff Investment Securities LLC, and, a California appeals court halts a class action filed by indie rockers over a magazine’s cigarette ads. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2010 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
